Steve Frisken, CEO Cylite Pty Ltd, was honoured to be the feature article in the June 2020 edition of mivision. Find out where it all started in this article by mivision’s Melanie Kell.
“Grant said OCT had great potential for optometry and ophthalmology, but the biggest problem was the eye moves too much to enable the acquisition of scans that are true enough to get accurate eye measurements. He set me the challenge to come up with a solution.”
With its ability to overcome constraints related to eye motion artefacts, its true volumetric imaging capabilities, and its micron-level accuracy, HP-…
Read more
The transition into production and sales is proving a pivotal moment for Cylite, as we embark on a crucial scale-up to bring our technology to the wor…
Read more
Kylee Hall, a proven leader in the Australasian Ophthalmic Industry, has taken over as Cylite’s CEO from renowned scientist Dr Steve Frisken. Ms Hall…
Read moreTo find out how HP-OCT™ can benefit you, your practice, and your patients, register your interest today.
Register your interest